Patents by Inventor Anjum ZAFAR

Anjum ZAFAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR MODULATING CANCER STEM CELLS
    Publication number: 20210121496
    Abstract: Disclosed are compositions and methods that use lysine demethylase inhibitors for inhibiting the growth of cancer stem cells or tumor initiating cells, for enhancing the biological effects of chemotherapeutic drugs or irradiation on cancer cells and/or for preventing cancer recurrence.
    Type: Application
    Filed: June 29, 2020
    Publication date: April 29, 2021
    Inventors: Sudha RAO, Anjum ZAFAR
  • Compositions for Modulating Cancer Stem Cells and Uses Therefor
    Publication number: 20200289437
    Abstract: Disclosed are compositions and methods for modulating cancer stem cells. More particularly, the present invention discloses the use of lysine demethylase (LSD) inhibitors and protein kinase C theta inhibitors (PKC-?) for inhibiting the growth of LSD- and/or PKC-?-overexpressing cells including cancer stem cells, for enhancing the biological effects of chemotherapeutic drugs or irradiation on cancer cells, for treating cancer, including non-metastatic and metastatic cancer and/or for preventing cancer recurrence.
    Type: Application
    Filed: November 13, 2019
    Publication date: September 17, 2020
    Inventors: Sudha RAO, Anjum ZAFAR
  • Compositions for modulating cancer stem cells and uses therefor
    Patent number: 10485772
    Abstract: Disclosed are compositions and methods for modulating cancer stem cells. More particularly, the present invention discloses the use of lysine demethylase (LSD) inhibitors and protein kinase C theta inhibitors (PKC-?) for inhibiting the growth of LSD- and/or PKC-?-overexpressing cells including cancer stem cells, for enhancing the biological effects of chemotherapeutic drugs or irradiation on cancer cells, for treating cancer, including non-metastatic and metastatic cancer and/or for preventing cancer recurrence.
    Type: Grant
    Filed: August 25, 2015
    Date of Patent: November 26, 2019
    Assignee: EpiAxis Therapeutics Pty Ltd.
    Inventors: Sudha Rao, Anjum Zafar
  • METHODS AND COMPOSITIONS FOR MODULATING CANCER STEM CELLS
    Publication number: 20190262377
    Abstract: Disclosed are compositions and methods that use lysine demethylase inhibitors for inhibiting the growth of cancer stem cells or tumor initiating cells, for enhancing the biological effects of chemotherapeutic drugs or irradiation on cancer cells and/or for preventing cancer recurrence.
    Type: Application
    Filed: January 11, 2019
    Publication date: August 29, 2019
    Inventors: Sudha RAO, Anjum ZAFAR
  • Methods and compositions for modulating cancer stem cells
    Patent number: 10220053
    Abstract: Disclosed are compositions and methods that use lysine demethylase inhibitors for inhibiting the growth of cancer stem cells or tumor initiating cells, for enhancing the biological effects of chemotherapeutic drugs or irradiation on cancer cells and/or for preventing cancer recurrence.
    Type: Grant
    Filed: June 17, 2014
    Date of Patent: March 5, 2019
    Assignee: University of Canberra
    Inventors: Sudha Rao, Anjum Zafar
  • Stem cell modulation II
    Patent number: 10124001
    Abstract: Disclosed are methods and compositions for modulating cancer stem cells. More particularly, the present invention discloses the use of protein kinase C theta inhibitors (PKC-?) for inhibiting the growth of PKC-?-overexpressing cells including cancer stem cells, for enhancing the biological effects of chemotherapeutic drugs or irradiation on cancer cells, for treating cancer, including metastatic cancer and/or for preventing cancer recurrence.
    Type: Grant
    Filed: September 18, 2014
    Date of Patent: November 13, 2018
    Assignee: University of Canberra
    Inventors: Sudha Rao, Anjum Zafar
  • Compositions for Modulating Cancer Stem Cells and Uses Therefor
    Publication number: 20170266140
    Abstract: Disclosed are compositions and methods for modulating cancer stem cells. More particularly, the present invention discloses the use of lysine demethylase (LSD) inhibitors and protein kinase C theta inhibitors (PKC-?) for inhibiting the growth of LSD- and/or PKC-?-overexpressing cells including cancer stem cells, for enhancing the biological effects of chemotherapeutic drugs or irradiation on cancer cells, for treating cancer, including non-metastatic and metastatic cancer and/or for preventing cancer recurrence.
    Type: Application
    Filed: August 25, 2015
    Publication date: September 21, 2017
    Inventors: Sudha RAO, Anjum ZAFAR
  • Stem Cell Modulation II
    Publication number: 20160354367
    Abstract: Disclosed are methods and compositions for modulating cancer stem cells. More particularly, the present invention discloses the use of protein kinase C theta inhibitors (PKC-?) for inhibiting the growth of PKC-?-overexpressing cells including cancer stem cells, for enhancing the biological effects of chemotherapeutic drugs or irradiation on cancer cells, for treating cancer, including metastatic cancer and/or for preventing cancer recurrence.
    Type: Application
    Filed: September 18, 2014
    Publication date: December 8, 2016
    Applicant: University of Canberra
    Inventors: Sudha RAO, Anjum ZAFAR
  • Methods and compositions for modulating cancer stem cells
    Publication number: 20160143938
    Abstract: Disclosed are compositions and methods that use lysine demethylase inhibitors for inhibiting the growth of cancer stem cells or tumor initiating cells, for enhancing the biological effects of chemotherapeutic drugs or irradiation on cancer cells and/or for preventing cancer recurrence.
    Type: Application
    Filed: June 17, 2014
    Publication date: May 26, 2016
    Inventors: Sudha RAO, Anjum ZAFAR